71 related articles for article (PubMed ID: 18716515)
1. Male primary breast cancer found on FDG-PET/CT.
McEachen JC; Kuo PH
Clin Nucl Med; 2008 Sep; 33(9):630-2. PubMed ID: 18716515
[No Abstract] [Full Text] [Related]
2. A Case of a Man With Isolated Breast Metastasis From Lung Adenocarcinoma Incidentally Detected by FDG PET/CT.
Erhamamci S; Reyhan M; Canpolat T; Nursal GN; Yapar AF
Clin Nucl Med; 2016 Mar; 41(3):e146-8. PubMed ID: 26562574
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic performance of CT attenuation values of focal 18F-FDG avid breast lesions detected on whole-body PET-CT in postoperative breast cancer patients.
Plaza MJ; Collado-Mesa F; Bokhoor J; Alperin N; Yepes MM
Breast J; 2014; 20(3):235-42. PubMed ID: 24750508
[TBL] [Abstract][Full Text] [Related]
4. Incidental breast cancer in a male patient on cardiac PET-CT.
Rendl G; Rettenbacher L; Rodrigues M; Pirich C
Breast J; 2014; 20(6):660-2. PubMed ID: 25252023
[No Abstract] [Full Text] [Related]
5. An incidental male breast cancer of
Shi W; Li W
Asian J Surg; 2023 Apr; 46(4):1680-1681. PubMed ID: 36274001
[No Abstract] [Full Text] [Related]
6. Utility of combined (18)F-fluorodeoxyglucose-positron emission tomography and computed tomography in patients with cervical metastases from unknown primary tumors.
Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Oral Oncol; 2009 Mar; 45(3):218-24. PubMed ID: 18804404
[TBL] [Abstract][Full Text] [Related]
7. Role of whole body positron emission tomography/computed tomography scan with 18F-fluorodeoxyglucose in patients with biopsy proven tumor metastases from unknown primary site.
Pelosi E; Pennone M; Deandreis D; Douroukas A; Mancini M; Bisi G
Q J Nucl Med Mol Imaging; 2006 Mar; 50(1):15-22. PubMed ID: 16557200
[TBL] [Abstract][Full Text] [Related]
8. Unsuspected metastatic male breast nodule from synovial sarcoma detected by FDG PET.
Nair N; Basu S
Clin Nucl Med; 2005 Apr; 30(4):289-90. PubMed ID: 15764896
[TBL] [Abstract][Full Text] [Related]
9. [Incidental detection of Paget disease on ¹⁸F-FDG PET/CT scan in a patient with rectal cancer].
Mena LM; Hernández AC; Gallego M; Martínez T; Contreras JF
Rev Esp Med Nucl Imagen Mol; 2013 Mar; 32(2):117-8. PubMed ID: 23177337
[No Abstract] [Full Text] [Related]
10. Lymph node metastasis of squamous cell carcinoma from an unknown primary in the upper and middle neck: Impact of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography.
Deron PB; Bonte KM; Vermeersch HF; Van de Wiele C
Cancer Biother Radiopharm; 2011 Jun; 26(3):331-4. PubMed ID: 21711095
[TBL] [Abstract][Full Text] [Related]
11. Combined [18F]Fluorodeoxyglucose positron emission tomography and computed tomography (FDG-PET/CT) for detection of recurrent, 131I-negative thyroid cancer.
Finkelstein SE; Grigsby PW; Siegel BA; Dehdashti F; Moley JF; Hall BL
Ann Surg Oncol; 2008 Jan; 15(1):286-92. PubMed ID: 17882493
[TBL] [Abstract][Full Text] [Related]
12. The value of quantifying 18F-FDG uptake in thyroid nodules found incidentally on whole-body PET-CT.
Bogsrud TV; Karantanis D; Nathan MA; Mullan BP; Wiseman GA; Collins DA; Kasperbauer JL; Strome SE; Reading CC; Hay ID; Lowe VJ
Nucl Med Commun; 2007 May; 28(5):373-81. PubMed ID: 17414887
[TBL] [Abstract][Full Text] [Related]
13. Interesting image. Incidental diagnosis of prostate cancer by F-18 FDG PET/CT.
Monet A; Merino B; Lupo R
Clin Nucl Med; 2010 Jan; 35(1):34-5. PubMed ID: 20026972
[No Abstract] [Full Text] [Related]
14. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer staging in a single session: whole-body PET/CT mammography.
Heusner TA; Kuemmel S; Umutlu L; Koeninger A; Freudenberg LS; Hauth EA; Kimmig KR; Forsting M; Bockisch A; Antoch G
J Nucl Med; 2008 Aug; 49(8):1215-22. PubMed ID: 18632831
[TBL] [Abstract][Full Text] [Related]
16. Incidental finding of an endobronchial tumor by 18F-FDG PET/CT.
Navales I; Garcia JR; Alvarez-Moro FJ; Navarro A; Escobar I; Lomeña F
Rev Esp Med Nucl Imagen Mol; 2013; 32(4):271-2. PubMed ID: 23046638
[No Abstract] [Full Text] [Related]
17. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
[TBL] [Abstract][Full Text] [Related]
18. Ionising radiation-free whole-body MRI versus (18)F-fluorodeoxyglucose PET/CT scans for children and young adults with cancer: a prospective, non-randomised, single-centre study.
Klenk C; Gawande R; Uslu L; Khurana A; Qiu D; Quon A; Donig J; Rosenberg J; Luna-Fineman S; Moseley M; Daldrup-Link HE
Lancet Oncol; 2014 Mar; 15(3):275-85. PubMed ID: 24559803
[TBL] [Abstract][Full Text] [Related]
19. Extramedullary acute myeloid leukemia and the use of FDG-PET/CT.
Rao S; Langston A; Galt JR; Halkar RK
Clin Nucl Med; 2009 Jun; 34(6):365-6. PubMed ID: 19487847
[No Abstract] [Full Text] [Related]
20. Non-small cell lung cancer: whole-body MR examination for M-stage assessment--utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT.
Ohno Y; Koyama H; Onishi Y; Takenaka D; Nogami M; Yoshikawa T; Matsumoto S; Kotani Y; Sugimura K
Radiology; 2008 Aug; 248(2):643-54. PubMed ID: 18539889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
